An Integrative Transcriptome-Wide Analysis of Amyotrophic Lateral Sclerosis for the Identification of Potential Genetic Markers and Drug Candidates
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative neuromuscular disease. Although genome-wide association studies (GWAS) have successfully identified many variants significantly associated with ALS, it is still difficult to characterize the underlying biological mechanisms inducing ALS. In...
Main Authors: | Sungmin Park, Daeun Kim, Jaeseung Song, Jong Wha J. Joo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/3216 |
Similar Items
-
Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review
by: Rosa Luisa Potenza, et al.
Published: (2024-02-01) -
Causal Inference of Genetic Variants and Genes in Amyotrophic Lateral Sclerosis
by: Siyu Pan, et al.
Published: (2022-06-01) -
Depression in amyotrophic lateral sclerosis
by: Joanna Iłżecka
Published: (2021-10-01) -
Amyotrophic lateral sclerosis : advances and perspectives of neuronanomedicine /
by: Machtoub, Lina, author, et al.
Published: (2016) -
Iron Status May Not Affect Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study
by: Jiahao Cai, et al.
Published: (2021-03-01)